Semaglutide and tirzepatide are often mentioned in the same conversation about weight loss. If you are considering treatment, it is easy to focus on which medication gets the most attention. A more useful starting point is understanding which option, if either, fits your health needs and what treatment would involve.
At Image Weight Loss Centers, we help patients explore medical weight loss options in Houston. Use the questions below to prepare for a conversation with a qualified prescribing clinician. Bring your goals, current medication list, and questions about the practical details of care.
1. What is the difference between these medications?
Semaglutide acts on GLP-1 receptors; tirzepatide acts on both GIP and GLP-1 receptors. These
pathways help regulate appetite and food intake. Both have FDA-approved products for weight management, but they are different medications.
2. Am I a candidate for prescription treatment?
For adults, weight management medicines are generally considered at a BMI of 30 or higher, or 27 or higher with a weight-related condition. Eligibility also depends on the particular medicine and your medical history. Meeting a BMI threshold does not automatically mean a prescription is appropriate.
Ask your clinician: “What makes this option suitable for me, and what alternatives should we consider?” You should understand the reason behind the recommendation before making a decision.
3. What do the weight loss studies actually show?
In SURMOUNT-5, a 72-week randomized, open-label study of 751 adults with obesity without type 2 diabetes, average weight reduction was 20.2% with tirzepatide and 13.7% with semaglutide. Participants received their maximum tolerated weekly dose: tirzepatide 10 or 15 mg, or semaglutide 1.7 or 2.4 mg. The study was funded by Eli Lilly.
Those findings describe an average in a specific study population. They do not promise your result or compare every available dose or formulation. Ask how the evidence applies to your health history and the exact treatment being proposed.
A useful follow-up is, “What progress would you consider meaningful for me, and when would we reassess?” That keeps the discussion focused on your care instead of a headline percentage.
4. Which side effects and health risks matter for me?
Common side effects include nausea, vomiting, diarrhea, constipation, and abdominal discomfort. More serious risks include pancreatitis, gallbladder problems, and dehydration-related kidney injury. Both products carry boxed warnings about thyroid C-cell tumors seen in rodents; whether they cause these tumors in humans is unknown. They should not be used with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN 2), or after a serious allergic reaction to the relevant product.
Ask which symptoms need a call to the office and which require urgent care. Review your full health history, especially significant digestive problems, and ask how other prescriptions affect the decision. Your clinician should review the complete warnings with you; this article does not list every risk.
Do not combine semaglutide and tirzepatide. Their prescribing information advises against using them with other GLP-1 medicines.
5. How do pregnancy plans or birth control affect treatment?
These medicines are not used for weight loss during pregnancy. Tell the prescriber about pregnancy plans or breastfeeding before treatment. Wegovy labeling advises stopping it at least two months before a planned pregnancy.
Tirzepatide can affect oral hormonal birth control. Zepbound labeling advises switching to a non-oral method or adding a barrier method for four weeks after starting and for four weeks after each dose increase.
If any of these circumstances apply, ask for a clear plan before starting treatment or changing an existing prescription.
6. What exactly am I being prescribed, and what will it cost?
Ask for the product name, formulation, dispensing pharmacy, and written instructions. If a compounded preparation is proposed, ask why an FDA-approved product cannot meet your medical needs. Compounded medicines are not FDA-approved and do not undergo the same FDA review for safety, effectiveness, and quality before marketing.
The FDA has also reported dosing errors with compounded injectable GLP-1 medicines. Make sure you understand the prescribed amount and device; ask the care team or pharmacist to resolve any confusing instructions.
Request a cost estimate that separates medication from appointments, testing, supplies, and follow-up. Ask whether prices change with the dose. If you expect insurance coverage, confirm the requirements and your out-of-pocket cost for the specific prescription.
7. What happens after I start or reach my goal?
Weight management medication may be a long-term treatment when it remains effective and appropriate. Weight regain can occur after stopping. Discuss the maintenance plan early, including how the clinician will reassess benefits, side effects, and continued treatment.
Ask how nutrition and activity support fit into the program. Medication is used alongside these habits, and your plan should reflect your health, abilities, and routine. Discuss how appointments fit around work and other responsibilities.
Before leaving, make sure you can answer these questions:
• Who do I contact if I have side effects or cannot obtain my medication?
• When is my next follow-up, and what should I track until then?
• What should I do if I miss a dose or have a treatment interruption?
• How will we decide whether to continue, adjust, or change the plan?
Write down instructions specific to your prescription. Ask for clarification if the pharmacy label and the directions you received do not match.
Discuss your options with our Houston-area team
Image Weight Loss Centers has locations in Clear Lake, Pearland, Sugar Land, and Cypress/Jersey Village. Request a weight loss consultation to discuss available services and the evaluation process.
Bring your questions and ask the prescribing clinician to explain the expected benefits, relevant risks, and next steps for your situation.
General educational information for adults; not individualized medical advice. Treatment requires evaluation by a qualified prescribing clinician.
